Who
MVM Partners, LLC
Director
Company insider
Files Form 4 as: Director and 10% owner, MDxHealth SA; 10% owner, Paragon 28; 10% owner, OptiNose.
In numbers
- Trades disclosed
- 25
- Buys
- 2
- Sells
- 19
- Bought
- $5.0M
- Sold
- $38.6M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 23 Nov 2022
- Last trade
- 13 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 17 Aug 2026 | MDXH MDxHealth SADiagnostics & Labs | SEC FORM 4 Bought | $1000K2,202,643 at $0.454 | filing |
| 13 Mar 2025filed 13 Mar 2025 | Paragon 28 | SEC FORM 4 Sold | $13.6M1,044,295 at $13.04 | filing |
| 6 Mar 2025filed 6 Mar 2025 | Paragon 28 | SEC FORM 4 Sold | $2.1M164,664 at $13.01 | filing |
| 5 Mar 2025filed 6 Mar 2025 | Paragon 28 | SEC FORM 4 Sold | $7.7M590,224 at $13.02 | filing |
| 4 Mar 2025filed 6 Mar 2025 | Paragon 28 | SEC FORM 4 Sold | $8.1M619,747 at $12.99 | filing |
| 28 Jan 2025filed 29 Jan 2025 | Paragon 28 | SEC FORM 4 Sold | $1.0M84,323 at $11.94 | filing |
| 27 Jan 2025filed 29 Jan 2025 | Paragon 28 | SEC FORM 4 Sold | $315K27,142 at $11.62 | filing |
| 24 Jan 2025filed 27 Jan 2025 | Paragon 28 | SEC FORM 4 Sold | $290K25,026 at $11.60 | filing |
| 23 Jan 2025filed 27 Jan 2025 | Paragon 28 | SEC FORM 4 Sold | $234K20,136 at $11.63 | filing |
| 9 Dec 2024filed 10 Dec 2024 | Paragon 28 | SEC FORM 4 Sold | $145K14,403 at $10.05 | filing |
| 6 Dec 2024filed 10 Dec 2024 | Paragon 28 | SEC FORM 4 Sold | $257K25,485 at $10.07 | filing |
| 5 Dec 2024filed 6 Dec 2024 | Paragon 28 | SEC FORM 4 Sold | $565K55,818 at $10.13 | filing |
| 4 Dec 2024filed 6 Dec 2024 | Paragon 28 | SEC FORM 4 Sold | $184K18,109 at $10.14 | filing |
| 27 Nov 2024filed 29 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $43K4,256 at $10.00 | filing |
| 26 Nov 2024filed 29 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $441K44,014 at $10.03 | filing |
| 25 Nov 2024filed 26 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $109K10,835 at $10.09 | filing |
| 22 Nov 2024filed 26 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $733K72,133 at $10.16 | filing |
| 21 Nov 2024filed 22 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $1.1M107,366 at $10.41 | filing |
| 20 Nov 2024filed 22 Nov 2024 | Paragon 28 | SEC FORM 4 Sold | $1.5M147,581 at $10.28 | filing |
| 9 Jun 2023filed 13 Jun 2023 | Paragon 28 | SEC FORM 4 Code J | —2,903,275 at $0.00 | filing |
News
MDxHealth (NASDAQ:MDXH) versus Seres Therapeutics (NASDAQ:MCRB) Financial ComparisonMDXH · tickerreport.com · 21 Oct 2026
0 headlines in the last 90 days name MVM Partners, LLC; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.